Oldenburg, Johannes, Georg Goldmann, Natascha Marquardt, Silvia Horneff, Claudia Klein, Thilo Albert, and Ruwan Perera. “Real-World Clinical Experience of Extended Half-Life Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Comparison to Conventional Factor Products in Patients With Severe Hemophilia A”. Journal of Current Medical Research and Opinion 4, no. 05 (May 21, 2021): 950–960. Accessed May 20, 2024. http://cmro.in/index.php/jcmro/article/view/422.